Search Results 481-490 of 17722 for cellular cleansing
"We've seen very impressive results. CAR T-cell therapy is a living drug that relies on the innate ability of the patients' own immune cells to sense what's ...
CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/Refractory B Cell Malignancies. Rochester, Minn. The purpose of this study is to find out ...
Preparing to biomanufacture a new CAR-T cell therapy for B-cell cancers featured. Research. Preparing to biomanufacture a new CAR-T cell therapy for B-cell ...
The purpose of this study is to prospectively define the incidence of new and/or worsening hypertension in patients with B-cell malignancies on Bruton Tyrosine ...
Toxic cellular ooze linked to biological age, disease and disability featured image. Research. Toxic cellular ooze linked to biological age, disease and ...
AZD0486 As Monotherapy In Participants With Relapsed/Refractory (R/R) B-cell NHL. Rochester, Minn. This is a Phase 2 global, multi-center, open-label study ...
Further, these gains have been the result of interventions during the Consolidation (tandem autologous stem cell transplant) and Post-Consolidation ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!